10 results match your criteria: "i3S- Institute for Investigation and Innovation in Health[Affiliation]"
World J Urol
December 2023
School of Medicine of University of Minho, Braga, Portugal.
Purpose: Urinary incontinence (UI) is a common condition in women. The aim of this study is to analyze women with self-reported UI, focusing on socio-demographic data, health-related conditions and comorbidities, and their impact on healthcare resources.
Methods: We analyzed data from a population-based survey with a representative sample of Portuguese women aged ≥ 18 years (n = 10,465).
Eur Urol Focus
January 2024
Department of Urology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Background: Effective, well-tolerated novel treatments for overactive bladder (OAB) are lacking. The P2X3 receptor antagonist eliapixant demonstrated potential to reduce OAB symptoms in preclinical studies.
Objective: To evaluate the safety, tolerability, and efficacy of eliapixant in patients with OAB with urgency urinary incontinence (UUI).
Eur Urol
July 2023
Department of Urology, Hospital São João, Porto, Portugal; Faculty of Medicine, University of Porto, Porto, Portugal; I3S Institute for Investigation and Innovation in Health, University of Porto, Porto, Portugal. Electronic address:
PLoS One
October 2020
Laboratory Animal Science, IBMC-Institute of Molecular and Cellular Biology, University of Porto, Porto, Portugal.
High and variable pre-weaning mortality is a persistent problem in laboratory mouse breeding. Assuming a modest 15% mortality rate across mouse strains, means that approximately 1 million more pups are produced yearly in the EU to compensate for those which die. This paper presents the first large study under practical husbandry conditions to determine the risk factors associated with mouse pre-weaning mortality.
View Article and Find Full Text PDFJ Urol
August 2020
Department of Urology, Hospital São João, Faculty of Medicine of Porto and i3S Institute for Investigation and Innovation in Health, Porto, Brazil.
Curr Opin Urol
July 2020
Department of Urology, Centro Hospitalar Universitário de São João.
Purpose Of Review: This review aims to update the studies involving the treatment of lower urinary tract symptoms (LUTS) in neurogenic patients, published in the last two years.
Recent Findings: Treatment of neurogenic LUTS (NLUTS) patients with β3 adrenoreceptor agonists was investigated in real-life conditions. A randomized controlled trial compared the efficacy of antimuscarinics versus onabotulinum toxin A in neurogenic patients.
Front Neurosci
January 2020
Unit of Experimental Biology, Department of Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal.
Chemotherapy-induced peripheral neuropathy (CIPN) is a problem during cancer treatment and for cancer survivors but the central mechanisms underlying CIPN remain understudied. This study aims to determine if CIPN is associated with alterations of noradrenergic modulation of nociceptive transmission at the spinal cord. CIPN was induced in male Wistar rats by paclitaxel injections.
View Article and Find Full Text PDFPorto Biomed J
September 2017
Department of Biomedicine - Experimental Biology Unit, Faculty of Medicine of the University of Porto, Porto, Portugal.
J Biol Chem
April 2017
From the Biosciences National Laboratory, National Center for Research in Energy and Materials, Rua Giuseppe Maximo Scolfaro 10000, 13083-100 Campinas/SP, Brazil,
parasites have evolved a number of strategies to cope with the harsh environmental changes during mammalian infection. One of these mechanisms involves the functional gain that allows mitochondrial 2-Cys peroxiredoxins to act as molecular chaperones when forming decamers. This function is critical for parasite infectivity in mammals, and its activation has been considered to be controlled exclusively by the enzyme redox state under physiological conditions.
View Article and Find Full Text PDF